Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probac Mood
- Development stage
- Unknown
- Lead developer
- Bened Biomedical
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Probac Mood is a probiotic dietary supplement developed and marketed by Interpharma Group, a Thai pharmaceutical company. The product's primary active ingredient is *Lactobacillus plantarum* PS128, a specialized psychobiotic strain, along with additional components including inulin, resistant maltodextrin (Fibersol 2), Pharma GABA, and banana powder. Formulated as an oral supplement in sachets, Probac Mood is designed to support mental health and mood regulation by modulating the gut-brain axis. The PS128 strain specifically targets the production and regulation of neurotransmitters such as dopamine and serotonin. It is indicated for reducing anxiety and depression symptoms, managing stress, improving sleep quality, and supporting individuals with autism spectrum disorder, Parkinson's disease, and dementia. As a consumer health product, it is approved as a dietary supplement in Thailand.
- Brand names
- Probac Mood
02
Targets
GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on Probac Mood.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probac Mood.